Clinical Trial Update: Mesenchymal Stromal Cell Therapy in Renal Recipients [Phase 2]

View source ↗

Summary

Phase 2 trial update of mesenchymal stromal cell therapy for renal transplant rejection and fibrosis in renal recipients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Fibrosis
• Renal Transplant Rejection

Drugs mentioned

• Mesenchymal Stromal Cell Therapy

Snippet

Sponsor: Leiden University Medical Center | Conditions: Renal Transplant Rejection, Fibrosis | Phase 2 | Status: UNKNOWN